| Issue Date | Title | Author(s) |
| 2020-08-20 | Are Medicinal Plants an Alternative Strategy to Combat COVID-19? | Prasher, P; Sharma, M; Gupta, G; Chellappan, DK; Dua, K |
| 2020-08 | Letter to the Editor: Integrating the Roles of Pharmacy Practice and Drug Delivery in Mitigating COVID-19. | Prasher, P; Sharma, M; Singh, L; Kumar Chellappan, D; Shukla, S; Pont, LG; Williams, KA; Dua, K |
| 2020-08 | The Impact of COVID-19 Pandemic Infection in Patients Admitted to the Hospital for Reasons Other Than COVID-19 Infection. | Rawat, S; Singh Dhramshaktu, I; Pathak, S; Kumar Singh, S; Singh, H; Mishra, A; Gilhotra, R; Kumar Chellappan, D; Dua, K; Gupta, G |
| 2020-08 | Gender and Age Differences Reveal Risk Patterns in COVID-19 Outbreak. | Singh, Y; Gupta, G; Mishra, A; Chellappan, DK; Dua, K |
| 2020-09 | COVID-19 transmission through host cell directed network of GPCR. | Singh, Y; Gupta, G; Satija, S; Pabreja, K; Chellappan, DK; Dua, K |
| 2020-01 | COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. | Aljabali, AAA; Bakshi, HA; Satija, S; Meenu,; Prasher, P; Ennab, RM; Chellappan, DK; Gupta, G; Negi, P; Goyal, R; Sharma, A; Mishra, V; Dureja, H; Dua, K; Tambuwala, MM |
| 2021-02-24 | An overview of vaccine development for COVID-19 | Shahcheraghi, SH; Ayatollahi, J; Aljabali, AA; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Katari, NK; Mehta, M; Satija, S; Dureja, H; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Gupta, G; Dua, K; Lotfi, M; Bakshi, HA; Tambuwala, MM |
| 2020-09 | Vesicular drug delivery systems as theranostics in COVID-19. | Satija, S; Mehta, M; Sharma, M; Prasher, P; Gupta, G; Chellappan, DK; Dua, K |
| 2020-07-14 | SARS-CoV-2 induces transcriptional signatures in human lung epithelial cells that promote lung fibrosis. | Xu, J; Xu, X; Jiang, L; Dua, K; Hansbro, PM; Liu, G |
